Back
Aquestive Therapeutics Stock Predictions
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68
AQST
Aquestive Therapeutics
Last Price:
5.00
Seasonality Move:
11.7%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Aquestive Therapeutics Stock Forecast
-
Is Aquestive Therapeutics Stock Undervalued?
The current Aquestive Therapeutics [AQST] share price is $4.84. The Score for AQST is 68, which is 36% above its historic median score of 50, and infers lower risk than normal. - AQST is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Aquestive Therapeutics Stock Go Up Next Year?
Data Unavailable
Aquestive Therapeutics Stock Rating
Data Unavailable
Aquestive Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aquestive.com
52-Week Data
52-Week High:
6.23
52-Week Low:
1.25
Prediction Charts
Market Cap:
440.73M
Price in USD:
4.84
Volume:
1.08M
Beta:
2.75
Technical Analysis
SMA50:
3.75
SMA100:
3.39
SMA200:
3.28
52-Wk Change:
191.57%
Stock Predictions
-
Is Aquestive Therapeutics stock public?
Yes, Aquestive Therapeutics is a publicly traded company. -
What is the Aquestive Therapeutics stock quote today?
The Aquestive Therapeutics stock price is 4.84 USD today. -
How to buy Aquestive Therapeutics stock online?
You can buy Aquestive Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-26 | 4.55 | 4.45 | 4.55 | 4.29 |
| Aug-27 | 4.43 | 4.63 | 4.65 | 4.36 |
| Aug-28 | 4.59 | 4.55 | 4.63 | 4.43 |
| Aug-29 | 4.58 | 4.40 | 4.59 | 4.40 |
| Aug-30 | 4.45 | 4.53 | 4.54 | 4.33 |
| Sep-3 | 4.43 | 4.19 | 4.58 | 4.16 |
| Sep-4 | 4.15 | 4.24 | 4.46 | 4.13 |
| Sep-5 | 4.26 | 4.24 | 4.33 | 4.18 |
| Sep-6 | 4.23 | 4.19 | 4.27 | 4.10 |
| Sep-9 | 4.24 | 4.67 | 4.72 | 4.20 |
| Sep-10 | 4.69 | 4.61 | 4.75 | 4.45 |
| Sep-11 | 4.67 | 4.95 | 4.98 | 4.56 |
| Sep-12 | 4.94 | 4.55 | 4.94 | 4.51 |
| Sep-13 | 4.60 | 4.84 | 4.84 | 4.60 |
Aquestive Therapeutics Earnings
Data Unavailable
Aquestive Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
* Aquestive Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.